Author

P. Bijlenga

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1 Organism:rat· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. F. Cayron· 1 shared B. R. Kwak· 1 shared D. Martinez Bedoya· 1 shared D. Migliorini· 1 shared E. Allemann· 1 shared E. Marinari· 1 shared J. Haemmerli· 1 shared K. Schaller· 1 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. F. Cayron

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Enhanced intracranial aneurysm development in a rat model of polycystic kidney disease.

A. F. Cayron, S. Morel, M. Azam, J. Haemmerli, T. Aoki, P. Bijlenga, E. Allemann, B. R. Kwak

This study shows that PCK rats, a model of polycystic kidney disease, develop intracranial aneurysms more rapidly and have increased aortic dissection risk due to anatomical and vascular changes.

bioRxiv · Feb 28, 2024Pathology

PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma

D. Martinez Bedoya, E. Marinari, S. Davanture, L. Castillo Cantero, S. Erraiss, M. Dockerill, S. Barluenga Badiola, N. Winssinger, K. Schaller, P. Bijlenga, S. Momjian, P. Hammel, P. Cosson, P. R. Walker, V. Dutoit, D. Migliorini

This study develops and validates anti-PTPRZ1 RNA CAR-T cells for glioblastoma treatment, showing antigen-specific and bystander antitumor activity in preclinical models.

bioRxiv · Dec 23, 2023Immunology